FDA official announcements and regulatory filings

Supreme Court Overturns 40-Year Chevron Doctrine in 6-3 Vote, Curtails Federal Regulatory Power

Jul 1, 2024, 11:50 AM

The U.S. Supreme Court has overturned the Chevron doctrine, a legal principle established in 1984 that required courts to defer to federal agencies' reasonable interpretations of ambiguous statutes. This landmark decision, which came with a 6-3 vote, is expected to significantly curtail the regulatory power of federal agencies, impacting areas such as environmental regulations, healthcare, and labor laws. The ruling is seen as a major victory for conservatives and a culmination of efforts to reduce the administrative state's influence. It also poses challenges to President Biden's regulatory agenda, including his efforts to cut tailpipe emissions. The decision has sparked widespread debate about its implications for democracy and the balance of power between the judiciary and federal agencies. One of the most imminent challenges may come over FDA regulation, specifically its plan to regulate lab-developed tests. The case, Loper Bright Enterprises, involved a family fishing company and marks the end of a 40-year precedent.